Electronic ISSN 2287-0237
Pradeep B, Nagamadhu M, Banji D, et al. Valacyclovir: Development, Treatment and Pharmacokinetics. Int J Appli Bio Pharmaceu Techno 2010;I(3):1076-83.
Perry CM, Faulds D. Valacyclovir: A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Drugs 1996;52(5):754-72.
Valtrex (Valacyclovir hydrochloride) prescribing information, Glaxo Wellcome Inc. Revised:12/2019. (Accessed April 1, 2020, at https://www.gsksource.com/pharma/content/dam/ GlaxoSmithKline/US/en/Prescribing_Information/Valtrex/ pdf/VALTREX-PI-PIL.PDF).
Chatis PA, Crumpacker CS. Resistance of herpesvirus to antiviral drugs. Antimicrob Agents Chemother 1992;36(8):1589-95.
Patel R. Valacyclovir: development, clinical utility and po- tential. Expert Opin Investg Drug 1997;6(2):173-89.
Acosta EP, Fletcher CV. Valacyclovir. Ann Pharmacothery other 1997;31(2):185-91
ClinCalc.com. Acyclovir. ( (Accessed April 1, 2020, at https:// clincalc.com/DrugStats/Drugs/acyclovir).
Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician 2008;78(6):743-50
Fleischer R, Johnson M. Acyclovir nephrotoxicity: A case report highlighting the importance of prevention, detection, and treatment of acyclovir-induced nephropathy. Case Rep Med 2010;2010. Doi: 10.1155/2010/602783
Valacyclovir-LiverTox-NCBI Bookshelf. (Accessed April 1, 2020, at https://www.ncbi.nih.gov/books/NBK548655)
Lam NN, Weir MA, Yao Z, et al. Risk of Acute Kidney Injury From Acyclovir: A Population-Based Study. Am J Kidney Dis 2013;61(5):723-29
Kitano A, Motohashi H, Takayama A, et al. Valacyclovir-Induced Acute Kidney Injury in Japanese Patients Based on the PMDAAdverse Drug Reactions Reporting Database. Ther Innov Regul Sci 2015;49(1):81-5.
Lee EU, Jang HN, Cho HS, et al. The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration. Ren Fail 2018;40(1):688–93.
Zhihua Y, Jinhai S. Acute kidney injury and neuropsychiatric reactions with anti-herpesvirus drugs: Analysis of spontaneously reported adverse events. Open Sci J Phar Pharmaco 2017;5(4):19-25.
Lorenzo CSV, Pedro SD, Benito AI, et al. Acyclovir crystalluria: A rare secondary effect of a common drug. Pediatr Ther 2016. DOI: 10.4172/2161-0665.1000287.
Vachvanichsanong P, Patamasucon P, Malagon M, et al. Acute renal failure in a child associated with acyclovir. Pediatr Nephrol 1995;9:346-7.
Ünsal MA. A case report: Acute renal injury with a single oral dose of Valacyclovir. Haydarpasa Numune Med J 2019;59(2):186-7.
Meur YL, Mons S, Moesch C, et al. The renal safety of high doses of Valacyclovir for prevention of cytomegalovirus infection after renal transplantation. Nephrol Dial Transplant 2000;15(3):442.
Lam NN, Fleet JL, McArthur E, et al. Higher dose versus lower dose of antiviral therapy in the treatment of herpes zoster infection in the elderly: a matched retrospective population-based cohort study. BMC Pharmacol Toxicol 2014;15:48.
Feinberg JE, Hurwitz S, Cooper D, et al. A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. J Infect Dis 1998;177(1):48-56.
Inaba I, Kondo Y, Iwasaki S, et al. Risk evaluation for acute kidney injury induced by the concomitant use of valacyclovir, analgesics, and renin–angiotensin system inhibitors: The detection of signals of drug–drug interactions. Front Pharmacol 2019;10:874.
Yue Z, Shi J, Jiang P, et al. Acute kidney injury during concomitant use of Valacyclovir and loxoprofen: detecting drug–drug interactions in a spontaneous reporting system. Pharmacoepidemiol Drug Saf 2014;23(11):1154-9.
Sugimoto T, Yasuda M, Sakaguchi M, et al. Oliguric acute renal failure following oral Valacyclovir therapy. QJM 2008;101(2):164-6.
Dornbierer M, Lezhoeva E, Dhayat NA. Acute renal failure and severe neurotoxicity due to Valacyclovir. J Case Rep Med 2018:7.DOI: 10.4303/jcrm/115
Murakami T, Akimoto T, Okada M, et al. Valacyclovir neurotoxicity and nephrotoxicity in an elderly patient complicated by hyponatremia. Drug Target Insights 2018;12: 1177392818782899.
Yoshimura T, Kawasaki T, Shirota A, et al. Valacyclovir- induced neurotoxicity in a patient with a preserved renaunction. Intern Med 2018;57(21):3213-6.
